VolitionRx Limited Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
VolitionRx Limited (VNRX) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of -$72.31 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2026-08-13
- VolitionRx Limited other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-06-30 was -$72.31K, a 112.55% decline year-over-year.
- VolitionRx Limited other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-06-30 was $576.00K, a 2401.72% increase year-over-year.
- VolitionRx Limited other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2024-06-30 was $23.02K.
- VolitionRx Limited other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2019-09-30 was $401.31K, a 765.82% increase year-over-year.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month as first filed | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$72.31K 10-Q · filed 2026-08-13 | -$206.62K 10-Q · filed 2026-08-13 | |||
| 2025-06-30 | $576.00K 10-Q · filed 2026-08-13 | -$576.00K 10-Q · filed 2025-08-14 | $829.92K 10-Q · filed 2026-08-13 | -$829.92K 10-Q · filed 2025-08-14 | |
| 2024-06-30 | $23.02K 10-Q · filed 2025-08-14 | $38.31K 10-Q · filed 2025-08-14 | |||
| 2019-09-30 | $401.31K 10-Q · filed 2019-11-12 | $451.22K derived: sum of 2 quarters · filed 2019-11-12 | $427.17K derived: sum of 3 quarters · filed 2019-11-12 | ||
| 2019-06-30 | $49.91K 10-Q · filed 2019-11-12 | $25.86K derived: sum of 2 quarters · filed 2019-11-12 | |||
| 2019-03-31 | -$24.05K 10-Q · filed 2019-11-12 | ||||
| 2018-09-30 | $46.35K 10-Q · filed 2019-11-12 | $178.51K derived: sum of 2 quarters · filed 2019-11-12 | $193.45K derived: sum of 3 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $132.16K 10-Q · filed 2019-11-12 | $147.10K derived: sum of 2 quarters · filed 2019-11-12 | |||
| 2018-03-31 | $14.95K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |